Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tonix Pharma (TNXP)
NASDAQ:TNXP
Holding TNXP?
Track your performance easily
TNXP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.13 - $26.57
Previous Close$0.15
Volume10.25M
Average Volume (3M)21.11M
Market Cap
$18.86M
Enterprise Value$23.96M
Total Cash (Recent Filing)$4.16M
Total Debt (Recent Filing)$9.26M
Price to Earnings (P/E)―
Beta2.86
Next Earnings
Nov 04, 2024EPS Estimate
-$2.93Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-22.15
Shares Outstanding22,004,159
10 Day Avg. Volume37,755,720
30 Day Avg. Volume21,105,765
Standard Deviation0.39
R-Squared0.08
Alpha-0.14
Financial Highlights & Ratios
Price to Book (P/B)0.08
Price to Sales (P/S)0.37
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.76
Enterprise Value/Gross Profit7.92
Enterprise Value/Ebitda-0.16
Forecast
1Y Price Target
$11.00Price Target Upside7357.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Tonix Pharma News
PremiumCompany Announcements
Tonix Pharma Unveils Promising TNX-1700 Cancer Data
PremiumCompany Announcements
Tonix Pharma Partners for Vaccine Clinical Trial
PremiumCompany Announcements
Tonix Pharma Showcases Promising TNX-801 Vaccine ResultsOwnership Overview
6.83%
Insiders
0.14% Mutual Funds
0.07% Other Institutional Investors
92.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TNXP FAQ
What was Tonix Pharma’s price range in the past 12 months?
Tonix Pharma lowest stock price was $0.13 and its highest was $26.57 in the past 12 months.
What is Tonix Pharma’s market cap?
Currently, no data Available
When is Tonix Pharma’s upcoming earnings report date?
Tonix Pharma’s upcoming earnings report date is Nov 04, 2024 which is 5 days ago.
How were Tonix Pharma’s earnings last quarter?
Tonix Pharma released its earnings results on Aug 19, 2024. The company reported -$19.28 earnings per share for the quarter, missing the consensus estimate of -$3.273 by -$16.007.
Is Tonix Pharma overvalued?
According to Wall Street analysts Tonix Pharma’s price is currently Undervalued.
Does Tonix Pharma pay dividends?
Tonix Pharma does not currently pay dividends.
What is Tonix Pharma’s EPS estimate?
Tonix Pharma’s EPS estimate is -$2.93.
How many shares outstanding does Tonix Pharma have?
Tonix Pharma has 127,874,520 shares outstanding.
What happened to Tonix Pharma’s price movement after its last earnings report?
Tonix Pharma reported an EPS of -$19.28 in its last earnings report, missing expectations of -$3.273. Following the earnings report the stock price went down -2.222%.
Which hedge fund is a major shareholder of Tonix Pharma?
Currently, no hedge funds are holding shares in TNXP
---
Tonix Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (7357.63% Upside)
$11.00 (7357.63% Upside)
Blogger Sentiment
Bullish
TNXP Sentiment 66%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 17.1%
Last 30 Days ▲ 17.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.46%
12-Months-Change
Fundamentals
Return on Equity
-163.24%
Trailing 12-Months
Asset Growth
-55.99%
Trailing 12-Months
Company Description
Tonix Pharma
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.
---
TNXP Stock 12 Month Forecast
Average Price Target
$11.00
▲(7357.63% Upside)
Technical Analysis
Best Analysts Covering TNXP
1 Year
1 Year Success Rate
0/16 ratings generated profit
1 Year Average Return
-86.36%
reiterated a buy rating 5 months ago
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -86.36% per trade.
---